Annette Von Drygalski

Title: Annette Von Drygalski: Inventor in Hemostasis and Bleeding Treatment.

Introduction

Annette Von Drygalski is an inventor associated with research into treatments for bleeding and hypocoagulation. Her listed patent work addresses approaches to preventing or treating these conditions, including in people with inherited or acquired bleeding disorders.

Latest Patents

The supplied information lists one patent for Von Drygalski: “Therapy for Treatment or Prevention of Conditions Associated with Bleeding or Hypocoagulation.” The invention describes methods and compositions involving factor Va (FVa), preferably an activated protein C (APC)-resistant form, alone or in combination with factor VIIa (FVIIa). The application proposes that combining FVa and FVIIa may provide a synergistic benefit in preventing or treating bleeding.

The described potential applications include hemophilia, acquired bleeding disorders, trauma, surgery, hemorrhagic stroke, shock, and bleeding associated with anticoagulant use. The patent also discusses using APC-resistant FVa, alone or with other procoagulant or prohemostatic agents, to address bleeding associated with APC overproduction or anticoagulant therapy. The supplied record identifies 1 patent.

Career Highlights

Von Drygalski is associated with the University of California and Scripps Research Institute. Her patent work reflects an interest in hemostasis and therapeutic strategies for restoring or supporting blood clotting in people at risk of bleeding.

Collaborations

The supplied information names John H. Griffin and Andrew Gale as coworkers associated with Von Drygalski’s work.

Conclusion

Annette Von Drygalski’s listed invention focuses on potential treatments for bleeding and hypocoagulation, including approaches that combine clotting factors to support hemostasis.